OMGA

Omega Therapeutics (OMGA)

About Omega Therapeutics (OMGA)

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Details

Daily high
$1.00
Daily low
$0.94
Price at open
$0.97
52 Week High
$6.30
52 Week Low
$0.94
Market cap
52.9M
Dividend yield
0.00%
Volume
252,117
Avg. volume
183,304
P/E ratio
-.67

Omega Therapeutics News

Details

Daily high
$1.00
Daily low
$0.94
Price at open
$0.97
52 Week High
$6.30
52 Week Low
$0.94
Market cap
52.9M
Dividend yield
0.00%
Volume
252,117
Avg. volume
183,304
P/E ratio
-.67